Folic acid, also known as folate or Vitamin B9, is a member of the B vitamin family and an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. For example, folic acid is present in green vegetables, beans, avocado, and some fruits.
The global Folic Acid Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In order to function within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as听Methotrexate听as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. When used in high doses such as for cancer therapy, or in low doses such as for Rheumatoid Arthritis or psoriasis,听Methotrexate听impedes the body's ability to create folic acid. This results in a deficiency of coenzymes and a resultant buildup of toxic substances that are responsible for numerous adverse side effects. As a result, supplementation with 1-5mg of folic acid is recommended to prevent deficiency and a number of side effects associated with MTX therapy including mouth ulcers and gastrointestinal irritation.听Leucovorin听(also known as folinic acid) supplementation is typically used for high-dose MTX regimens for the treatment of cancer. Levoleucovorin and leucovorin are analogs of tetrahydrofolate (THF) and are able to bypass DHFR reduction to act as a cellular replacement for the co-factor THF.
This report aims to provide a comprehensive presentation of the global market for Folic Acid Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Folic Acid Tablets.
Report Scope
The Folic Acid Tablets market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Folic Acid Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Folic Acid Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
A锛哯 Pharmaceutical
Endo International
Cardinal Health
Leading Pharma, LLC
Meiaojian
Sunota
Scrianen
Fishburg
Meydunlg
Elevit
Natures Bounty
Forceval
Nutrilite
Osteroform
Ferguson
By-Health
Lisheng Pharmaceutical
Renhe Pharmacy
SAN JIU ENTERPRISE GROUP
Segment by Type
1mg
5mg
Other
Segment by Application
Pregnancy Lady
Pregnant Lady
Lactating Lady
Child
Men
General
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Folic Acid Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Folic Acid Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Folic Acid Tablets Market Overview
1.1 Product Overview and Scope of Folic Acid Tablets
1.2 Folic Acid Tablets Segment by Type
1.2.1 Global Folic Acid Tablets Market Value Comparison by Type (2024-2030)
1.2.2 1mg
1.2.3 5mg
1.2.4 Other
1.3 Folic Acid Tablets Segment by Application
1.3.1 Global Folic Acid Tablets Market Value by Application: (2024-2030)
1.3.2 Pregnancy Lady
1.3.3 Pregnant Lady
1.3.4 Lactating Lady
1.3.5 Child
1.3.6 Men
1.3.7 General
1.3.8 Other
1.4 Global Folic Acid Tablets Market Size Estimates and Forecasts
1.4.1 Global Folic Acid Tablets Revenue 2019-2030
1.4.2 Global Folic Acid Tablets Sales 2019-2030
1.4.3 Global Folic Acid Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Folic Acid Tablets Market Competition by Manufacturers
2.1 Global Folic Acid Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Folic Acid Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Folic Acid Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Folic Acid Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Folic Acid Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Folic Acid Tablets, Product Type & Application
2.7 Folic Acid Tablets Market Competitive Situation and Trends
2.7.1 Folic Acid Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Folic Acid Tablets Players Market Share by Revenue
2.7.3 Global Folic Acid Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Folic Acid Tablets Retrospective Market Scenario by Region
3.1 Global Folic Acid Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Folic Acid Tablets Global Folic Acid Tablets Sales by Region: 2019-2030
3.2.1 Global Folic Acid Tablets Sales by Region: 2019-2024
3.2.2 Global Folic Acid Tablets Sales by Region: 2025-2030
3.3 Global Folic Acid Tablets Global Folic Acid Tablets Revenue by Region: 2019-2030
3.3.1 Global Folic Acid Tablets Revenue by Region: 2019-2024
3.3.2 Global Folic Acid Tablets Revenue by Region: 2025-2030
3.4 North America Folic Acid Tablets Market Facts & Figures by Country
3.4.1 North America Folic Acid Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Folic Acid Tablets Sales by Country (2019-2030)
3.4.3 North America Folic Acid Tablets Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Folic Acid Tablets Market Facts & Figures by Country
3.5.1 Europe Folic Acid Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Folic Acid Tablets Sales by Country (2019-2030)
3.5.3 Europe Folic Acid Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Folic Acid Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Folic Acid Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Folic Acid Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Folic Acid Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Folic Acid Tablets Market Facts & Figures by Country
3.7.1 Latin America Folic Acid Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Folic Acid Tablets Sales by Country (2019-2030)
3.7.3 Latin America Folic Acid Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Folic Acid Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Folic Acid Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Folic Acid Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Folic Acid Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Folic Acid Tablets Sales by Type (2019-2030)
4.1.1 Global Folic Acid Tablets Sales by Type (2019-2024)
4.1.2 Global Folic Acid Tablets Sales by Type (2025-2030)
4.1.3 Global Folic Acid Tablets Sales Market Share by Type (2019-2030)
4.2 Global Folic Acid Tablets Revenue by Type (2019-2030)
4.2.1 Global Folic Acid Tablets Revenue by Type (2019-2024)
4.2.2 Global Folic Acid Tablets Revenue by Type (2025-2030)
4.2.3 Global Folic Acid Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Folic Acid Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Folic Acid Tablets Sales by Application (2019-2030)
5.1.1 Global Folic Acid Tablets Sales by Application (2019-2024)
5.1.2 Global Folic Acid Tablets Sales by Application (2025-2030)
5.1.3 Global Folic Acid Tablets Sales Market Share by Application (2019-2030)
5.2 Global Folic Acid Tablets Revenue by Application (2019-2030)
5.2.1 Global Folic Acid Tablets Revenue by Application (2019-2024)
5.2.2 Global Folic Acid Tablets Revenue by Application (2025-2030)
5.2.3 Global Folic Acid Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Folic Acid Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Folic Acid Tablets Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 A锛哯 Pharmaceutical
6.2.1 A锛哯 Pharmaceutical Corporation Information
6.2.2 A锛哯 Pharmaceutical Description and Business Overview
6.2.3 A锛哯 Pharmaceutical Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 A锛哯 Pharmaceutical Folic Acid Tablets Product Portfolio
6.2.5 A锛哯 Pharmaceutical Recent Developments/Updates
6.3 Endo International
6.3.1 Endo International Corporation Information
6.3.2 Endo International Description and Business Overview
6.3.3 Endo International Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Endo International Folic Acid Tablets Product Portfolio
6.3.5 Endo International Recent Developments/Updates
6.4 Cardinal Health
6.4.1 Cardinal Health Corporation Information
6.4.2 Cardinal Health Description and Business Overview
6.4.3 Cardinal Health Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cardinal Health Folic Acid Tablets Product Portfolio
6.4.5 Cardinal Health Recent Developments/Updates
6.5 Leading Pharma, LLC
6.5.1 Leading Pharma, LLC Corporation Information
6.5.2 Leading Pharma, LLC Description and Business Overview
6.5.3 Leading Pharma, LLC Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Leading Pharma, LLC Folic Acid Tablets Product Portfolio
6.5.5 Leading Pharma, LLC Recent Developments/Updates
6.6 Meiaojian
6.6.1 Meiaojian Corporation Information
6.6.2 Meiaojian Description and Business Overview
6.6.3 Meiaojian Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Meiaojian Folic Acid Tablets Product Portfolio
6.6.5 Meiaojian Recent Developments/Updates
6.7 Sunota
6.6.1 Sunota Corporation Information
6.6.2 Sunota Description and Business Overview
6.6.3 Sunota Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sunota Folic Acid Tablets Product Portfolio
6.7.5 Sunota Recent Developments/Updates
6.8 Scrianen
6.8.1 Scrianen Corporation Information
6.8.2 Scrianen Description and Business Overview
6.8.3 Scrianen Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Scrianen Folic Acid Tablets Product Portfolio
6.8.5 Scrianen Recent Developments/Updates
6.9 Fishburg
6.9.1 Fishburg Corporation Information
6.9.2 Fishburg Description and Business Overview
6.9.3 Fishburg Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Fishburg Folic Acid Tablets Product Portfolio
6.9.5 Fishburg Recent Developments/Updates
6.10 Meydunlg
6.10.1 Meydunlg Corporation Information
6.10.2 Meydunlg Description and Business Overview
6.10.3 Meydunlg Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Meydunlg Folic Acid Tablets Product Portfolio
6.10.5 Meydunlg Recent Developments/Updates
6.11 Elevit
6.11.1 Elevit Corporation Information
6.11.2 Elevit Folic Acid Tablets Description and Business Overview
6.11.3 Elevit Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Elevit Folic Acid Tablets Product Portfolio
6.11.5 Elevit Recent Developments/Updates
6.12 Natures Bounty
6.12.1 Natures Bounty Corporation Information
6.12.2 Natures Bounty Folic Acid Tablets Description and Business Overview
6.12.3 Natures Bounty Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Natures Bounty Folic Acid Tablets Product Portfolio
6.12.5 Natures Bounty Recent Developments/Updates
6.13 Forceval
6.13.1 Forceval Corporation Information
6.13.2 Forceval Folic Acid Tablets Description and Business Overview
6.13.3 Forceval Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Forceval Folic Acid Tablets Product Portfolio
6.13.5 Forceval Recent Developments/Updates
6.14 Nutrilite
6.14.1 Nutrilite Corporation Information
6.14.2 Nutrilite Folic Acid Tablets Description and Business Overview
6.14.3 Nutrilite Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Nutrilite Folic Acid Tablets Product Portfolio
6.14.5 Nutrilite Recent Developments/Updates
6.15 Osteroform
6.15.1 Osteroform Corporation Information
6.15.2 Osteroform Folic Acid Tablets Description and Business Overview
6.15.3 Osteroform Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Osteroform Folic Acid Tablets Product Portfolio
6.15.5 Osteroform Recent Developments/Updates
6.16 Ferguson
6.16.1 Ferguson Corporation Information
6.16.2 Ferguson Folic Acid Tablets Description and Business Overview
6.16.3 Ferguson Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Ferguson Folic Acid Tablets Product Portfolio
6.16.5 Ferguson Recent Developments/Updates
6.17 By-Health
6.17.1 By-Health Corporation Information
6.17.2 By-Health Folic Acid Tablets Description and Business Overview
6.17.3 By-Health Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.17.4 By-Health Folic Acid Tablets Product Portfolio
6.17.5 By-Health Recent Developments/Updates
6.18 Lisheng Pharmaceutical
6.18.1 Lisheng Pharmaceutical Corporation Information
6.18.2 Lisheng Pharmaceutical Folic Acid Tablets Description and Business Overview
6.18.3 Lisheng Pharmaceutical Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Lisheng Pharmaceutical Folic Acid Tablets Product Portfolio
6.18.5 Lisheng Pharmaceutical Recent Developments/Updates
6.19 Renhe Pharmacy
6.19.1 Renhe Pharmacy Corporation Information
6.19.2 Renhe Pharmacy Folic Acid Tablets Description and Business Overview
6.19.3 Renhe Pharmacy Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Renhe Pharmacy Folic Acid Tablets Product Portfolio
6.19.5 Renhe Pharmacy Recent Developments/Updates
6.20 SAN JIU ENTERPRISE GROUP
6.20.1 SAN JIU ENTERPRISE GROUP Corporation Information
6.20.2 SAN JIU ENTERPRISE GROUP Folic Acid Tablets Description and Business Overview
6.20.3 SAN JIU ENTERPRISE GROUP Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.20.4 SAN JIU ENTERPRISE GROUP Folic Acid Tablets Product Portfolio
6.20.5 SAN JIU ENTERPRISE GROUP Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Folic Acid Tablets Industry Chain Analysis
7.2 Folic Acid Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Folic Acid Tablets Production Mode & Process
7.4 Folic Acid Tablets Sales and Marketing
7.4.1 Folic Acid Tablets Sales Channels
7.4.2 Folic Acid Tablets Distributors
7.5 Folic Acid Tablets Customers
8 Folic Acid Tablets Market Dynamics
8.1 Folic Acid Tablets Industry Trends
8.2 Folic Acid Tablets Market Drivers
8.3 Folic Acid Tablets Market Challenges
8.4 Folic Acid Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Bayer
A锛哯 Pharmaceutical
Endo International
Cardinal Health
Leading Pharma, LLC
Meiaojian
Sunota
Scrianen
Fishburg
Meydunlg
Elevit
Natures Bounty
Forceval
Nutrilite
Osteroform
Ferguson
By-Health
Lisheng Pharmaceutical
Renhe Pharmacy
SAN JIU ENTERPRISE GROUP
听
听
*If Applicable.